Table 2.
Prevalence n (%) | Crude | Model 1a | Model 2b | Model 3c | ||||||
---|---|---|---|---|---|---|---|---|---|---|
OR (95%CI) | p-value | OR (95%CI) | p-value | OR (95%CI) | p-value | OR (95%CI) | p-value | |||
Men | None-none (N = 133) | 39 (29.3) | Ref. | Ref. | Ref. | Ref. | ||||
None-active (N = 123) | 21 (17.1) | 0.50 (0.27–0.90) | 0.022 | 0.49 (0.27–0.91) | 0.024 | 0.48 (0.26–0.89) | 0.020 | 0.48 (0.26–0.90) | 0.021 | |
Active-none (N = 258) | 46 (17.8) | 0.52 (0.32–0.85) | 0.010 | 0.50 (0.30–0.84) | 0.008 | 0.54 (0.32–0.90) | 0.018 | 0.51 (0.31–0.86) | 0.012 | |
Active-active (N = 173) | 27 (15.6) | 0.45 (0.26–0.78) | 0.004 | 0.46 (0.26–0.83) | 0.009 | 0.46 (0.26–0.83) | 0.010 | 0.45 (0.25–0.81) | 0.008 | |
Women | None-none (N = 303) | 86 (28.4) | Ref. | Ref. | Ref. | Ref. | ||||
None-active (N = 198) | 39 (19.7) | 0.62 (0.40–0.95) | 0.029 | 0.62 (0.40–0.95) | 0.029 | 0.63 (0.41–0.98) | 0.040 | 0.63 (0.40–0.97) | 0.036 | |
Active-none (N = 267) | 51 (19.1) | 0.60 (0.40–0.88) | 0.010 | 0.58 (0.39–0.87) | 0.008 | 0.60 (0.40–0.88) | 0.010 | 0.59 (0.40–0.89) | 0.011 | |
Active-active (N = 174) | 34 (19.5) | 0.61 (0.39–0.96) | 0.033 | 0.63 (0.40–0.99) | 0.044 | 0.63 (0.40–0.99) | 0.046 | 0.63 (0.40–0.99) | 0.046 |
aModel l was adjusted for age, body mass index, years of education, alcohol intake, and Brinkman index.
bModel 2 was adjusted for Model 1 plus diabetes mellitus, cardiovascular diseases, and mild cognitive impairment.
cModel 3 was adjusted for Model 2 plus living alone.